The Valley Desk

NCT00874302 · Interventional trial

Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms

Overall registry status Withdrawn

Phase 3

Conditions Uterine Fibroids

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov